Rivera André, Menezes Antônio S, Gewehr Douglas Mesadri, Nascimento Bárbara, Miyawaki Isabele Ayumi, Rohde Luís E, Ternes Caique M P, Aryana Arash, d'Avila André
Department of Medicine, Nove de Julho University, São Bernardo do Campo, Brazil.
Federal University of Goiás, Goiânia, Brazil.
Heart Rhythm O2. 2025 Jan 4;6(3):317-328. doi: 10.1016/j.hroo.2024.12.008. eCollection 2025 Mar.
Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. Its effectiveness for persistent atrial fibrillation (PeAF) is limited, and the benefits of adjunctive posterior wall ablation are uncertain.
The purpose of this study was to perform a systematic review and meta-analysis of PVI with/without adjunctive PWI in patients with PeAF.
We systematically searched PubMed, Embase, Cochrane, and ClinicalTrials.gov databases for randomized controlled trials (RCTs) comparing PVI with/without PWI in patients with PeAF. Random-effects model was used for the meta-analysis. Atrial tachyarrhythmia (ATA) was a composite of AF, atrial flutter, or atrial tachycardia.
Our meta-analysis included eight RCTs with 1104 patients (546 PVI, 558 PVI plus PWI). Compared with PVI alone, adjunctive PWI significantly increased freedom from ATA recurrence (relative risk [RR] 1.13, 95% confidence interval [CI] 1.01-1.27, = .036). A subanalysis of patients with long-standing PeAF showed a greater effect of PWI (RR 1.76, 95% CI 1.02-3.04, = .04). A subgroup analysis of PWI techniques indicated no significant difference for ATA recurrence with box isolation alone (RR 1.13, 95% CI 0.97-1.33, = .12), whereas a pooled analysis using only studies with direct posterior wall ablation favored the adjunctive PWI group (RR 1.39, 95% CI 1.11-1.74, <.01). Adverse events did not significantly differ between groups.
Our findings support that adjunctive PWI to PVI is an effective strategy compared with PVI alone for reducing ATA recurrence in patients with PeAF without compromising safety. Notably, patients with long-standing PeAF may benefit more from PWI.
肺静脉隔离(PVI)是心房颤动(AF)消融的基石。其对持续性心房颤动(PeAF)的有效性有限,且辅助后壁消融的益处尚不确定。
本研究旨在对PeAF患者接受或不接受辅助后壁隔离(PWI)的PVI进行系统评价和荟萃分析。
我们系统检索了PubMed、Embase、Cochrane和ClinicalTrials.gov数据库,以查找比较PeAF患者接受或不接受PWI的PVI的随机对照试验(RCT)。荟萃分析采用随机效应模型。房性快速性心律失常(ATA)是AF、心房扑动或房性心动过速的综合表现。
我们的荟萃分析纳入了8项RCT,共1104例患者(546例接受PVI,558例接受PVI加PWI)。与单纯PVI相比,辅助PWI显著提高了ATA复发的自由度(相对风险[RR]1.13,95%置信区间[CI]1.01 - 1.27,P = 0.036)。对长期PeAF患者的亚组分析显示PWI的效果更大(RR 1.76,95% CI 1.02 - 3.04,P = 0.04)。PWI技术的亚组分析表明,仅采用盒状隔离时ATA复发无显著差异(RR 1.13,95% CI 0.97 - 1.33,P = 0.12),而仅使用直接后壁消融研究的汇总分析则支持辅助PWI组(RR 1.39,95% CI 1.11 - 1.74,P < 0.01)。两组间不良事件无显著差异。
我们的研究结果支持,与单纯PVI相比,PVI联合辅助PWI是一种有效的策略,可降低PeAF患者的ATA复发率且不影响安全性。值得注意的是,长期PeAF患者可能从PWI中获益更多。